Gordon, K., Warren, R., Gottlieb, A., Blauvelt, A., Thaçi, D., Leonardi, C., . . . Reich, K. (2020). Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2). Br J Dermatol.
Chicago Stili AlıntıGordon, K.B., et al. "Long‐term Efficacy of Certolizumab Pegol for the Treatment of Plaque Psoriasis: 3‐year Results From Two Randomized Phase III Trials (CIMPASI‐1 and CIMPASI‐2)." Br J Dermatol 2020.
MLA AlıntıGordon, K.B., et al. "Long‐term Efficacy of Certolizumab Pegol for the Treatment of Plaque Psoriasis: 3‐year Results From Two Randomized Phase III Trials (CIMPASI‐1 and CIMPASI‐2)." Br J Dermatol 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..